Whalen Wealth Management Inc. Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Whalen Wealth Management Inc. bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor bought 856 shares of the medical equipment provider's stock, valued at approximately $424,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Castleark Management LLC boosted its holdings in shares of Intuitive Surgical by 3.4% during the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after acquiring an additional 2,990 shares during the period. FourThought Financial Partners LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at $1,158,000. Longbow Finance SA acquired a new position in Intuitive Surgical in the 4th quarter valued at $4,431,000. Ewing Morris & Co. Investment Partners Ltd. bought a new position in Intuitive Surgical during the 4th quarter worth $454,000. Finally, Whalerock Point Partners LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $209,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $509.36 on Monday. The company has a market capitalization of $182.56 billion, a price-to-earnings ratio of 74.69, a price-to-earnings-growth ratio of 5.40 and a beta of 1.67. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00. The company's 50-day moving average is $528.03 and its 200 day moving average is $537.31.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period in the previous year, the business earned $1.50 EPS. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent research reports. Evercore ISI lowered their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research report on Wednesday, April 23rd. Barclays dropped their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Piper Sandler reduced their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Finally, Royal Bank Of Canada dropped their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $588.95.

Insiders Place Their Bets

In related news, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the sale, the executive vice president now owns 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 215 shares of the company's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $549.06, for a total transaction of $118,047.90. Following the sale, the senior vice president now directly owns 1,768 shares of the company's stock, valued at $970,738.08. The trade was a 10.84% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.